Profile data is unavailable for this security.
About the company
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
- Revenue in USD (TTM)93.22m
- Net income in USD-60.35m
- Incorporated2015
- Employees330.00
- LocationAkoya Biosciences Inc100 Campus Drive, 6Th FloorMARLBOROUGH 01762United StatesUSA
- Phone+1 (415) 765-6980
- Websitehttps://www.akoyabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare Inc | 36.37m | 6.65m | 117.18m | 35.00 | 17.56 | 2.22 | 17.07 | 3.22 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| TELA Bio Inc | 64.74m | -42.11m | 122.50m | 227.00 | -- | 26.74 | -- | 1.89 | -1.71 | -1.71 | 2.64 | 0.1163 | 0.8376 | 1.48 | 7.62 | 285,215.80 | -54.48 | -52.00 | -66.54 | -60.95 | 68.61 | 65.32 | -65.04 | -107.65 | 2.52 | -8.69 | 0.9343 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 136.19m | 82.00 | -- | 7.28 | -- | 4.42 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| EUDA Health Holdings Ltd | 3.81m | -17.99m | 140.16m | 106.00 | -- | -- | -- | 36.77 | -0.4821 | -0.4451 | 0.1487 | -0.1685 | 1.86 | -- | 7.21 | 35,957.55 | -876.41 | -- | -- | -- | 22.05 | -- | -472.08 | -- | -- | -43.68 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| Myomo Inc | 25.24m | -8.38m | 150.93m | 101.00 | -- | 16.24 | -- | 5.98 | -0.2294 | -0.2294 | 0.6847 | 0.3072 | 1.51 | 3.11 | 8.08 | 249,892.40 | -50.25 | -81.78 | -81.40 | -115.27 | 70.03 | 68.50 | -33.22 | -85.76 | 1.62 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Acme United Corp | 190.49m | 19.52m | 156.32m | 645.00 | 8.46 | 1.45 | 7.25 | 0.8206 | 4.94 | 4.94 | 46.90 | 28.77 | 1.18 | 2.09 | 5.84 | 295,331.70 | 12.13 | 7.09 | 14.25 | 8.29 | 39.37 | 35.72 | 10.25 | 5.50 | 1.91 | 7.06 | 0.2337 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| Cibus Inc | 4.15m | -445.40m | 156.87m | 183.00 | -- | 1.30 | -- | 37.77 | -22.43 | -22.43 | 0.1987 | 4.09 | 0.0071 | -- | 4.75 | 22,693.99 | -91.76 | -86.28 | -109.53 | -96.45 | -- | -- | -12,860.99 | -792.07 | -- | -3.23 | 0.0061 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 157.90m | 330.00 | -- | 7.09 | -- | 1.69 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Alpha Tau Medical Ltd | 0.00 | -27.63m | 158.03m | 121.00 | -- | 2.14 | -- | -- | -0.3966 | -0.3966 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -26.66 | -- | -28.28 | -- | -- | -- | -- | -- | -- | -- | 0.0681 | -- | -- | -- | 13.64 | -- | -- | -- |
| Pro-Dex Inc | 56.80m | 5.21m | 161.50m | 148.00 | 32.38 | 5.29 | 25.28 | 2.84 | 1.53 | 1.53 | 16.34 | 9.36 | 1.09 | 2.48 | 4.64 | 383,770.30 | 10.03 | 12.33 | 12.35 | 15.30 | 28.25 | 31.26 | 9.17 | 12.13 | 1.94 | 5.31 | 0.304 | 0.00 | 16.83 | 14.66 | -69.93 | -12.47 | -6.80 | -- |
| Senseonics Holdings Inc | 22.21m | -80.33m | 186.68m | 132.00 | -- | -- | -- | 8.41 | -0.1302 | -0.1302 | 0.036 | 0.0375 | 0.1774 | 3.79 | 5.94 | 168,219.70 | -64.16 | -73.65 | -81.31 | -106.97 | -10.49 | -40.41 | -361.77 | -649.86 | 2.38 | -27.98 | 0.7244 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Nevro Corp | 419.15m | -69.31m | 188.65m | 1.22k | -- | 0.6923 | -- | 0.4501 | -1.89 | -1.89 | 11.40 | 7.31 | 0.7244 | 1.10 | 6.01 | 344,976.10 | -11.98 | -13.64 | -14.11 | -16.68 | 68.02 | 68.54 | -16.54 | -20.67 | 3.76 | -8.21 | 0.4482 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| SANUWAVE Health Inc | 24.90m | -3.43m | 191.17m | 31.00 | -- | -- | -- | 7.68 | -3.55 | -3.55 | 8.17 | -12.56 | 1.24 | 3.90 | 8.34 | 803,064.50 | -17.07 | -136.54 | -- | -- | 71.57 | 69.13 | -13.79 | -189.60 | 0.0999 | 0.1199 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Stereotaxis Inc | 25.14m | -22.89m | 191.32m | 122.00 | -- | 17.70 | -- | 7.61 | -0.2717 | -0.2717 | 0.2988 | 0.1915 | 0.5268 | 1.40 | 3.82 | 206,090.20 | -45.19 | -25.02 | -69.91 | -34.12 | 56.14 | 67.57 | -85.79 | -41.90 | 0.9557 | -- | -- | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Accuray Inc | 444.20m | -20.08m | 192.08m | 987.00 | -- | 4.24 | -- | 0.4324 | -0.2032 | -0.2032 | 4.48 | 0.4503 | 0.9353 | 2.01 | 5.25 | 450,054.70 | -4.23 | -1.37 | -7.35 | -2.33 | 31.09 | 36.43 | -4.52 | -1.55 | 0.8655 | -0.0936 | 0.7901 | -- | -0.2355 | 1.29 | -67.51 | -- | -3.54 | -- |
Data as of Nov 13 2024. Currency figures normalised to Akoya Biosciences Inc's reporting currency: US Dollar USD
20.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Blue Water Life Science Advisors LPas of 30 Jun 2024 | 4.70m | 9.49% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.42m | 2.86% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 1.35m | 2.73% |
| Geode Capital Management LLCas of 30 Jun 2024 | 562.12k | 1.14% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 434.94k | 0.88% |
| Parkman Healthcare Partners LLCas of 30 Jun 2024 | 375.54k | 0.76% |
| Paragon JV Partners LLCas of 30 Jun 2024 | 350.00k | 0.71% |
| Polar Capital LLPas of 30 Jun 2024 | 329.76k | 0.67% |
| GSA Capital Partners LLPas of 30 Sep 2024 | 310.67k | 0.63% |
| Schonfeld Strategic Advisors LLCas of 30 Jun 2024 | 294.34k | 0.60% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
